CDKN2B-AS1 and lung cancer: Mechanistically, ANRIL regulates the expression of tumor suppressor genes, oncogenes, and cell cycle regulators, orchestrating a complex network of molecular interactions that drive oncogenic processes in lung cancer cells [225].